208.74USD-2.76%Mkt Cap: 46.01B $P/E: —Today
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that bind…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap46.01B $
Enterprise Value42.64B $
Revenue (TTM)—
Gross Profit-1.30B $
Net Income (TTM)-1.13B $
Revenue/Share—
Last Price208.74 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees883
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-31.81
PEG—
EV/EBITDA-26.35
EV/Revenue—
P/S—
P/B28.26
EPS (TTM)-8.74
EPS (Forward)-6.66
52W Range
35.4294% of range220.30
52W High220.30 USD
52W Low35.42 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-69.35%
ROA-48.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-897.74M $
CapEx (TTM)15.99M $
FCF Margin—
FCF Yield-1.55%
Net Debt-2.75B $
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity0.10
Current Ratio11.38
Quick Ratio11.12
Book Value/Sh7.493 USD
Cash/Share18.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)221.90 USD
Upside (mean)+6.3%
Target Range151.00 USD – 291.00 USD
$151.00+6.3% to mean$291.00
# Analysts21
Ownership
Shares Out.214.34M
Float184.45M
Insiders1.88%
Institutions100.98%
Short Interest
Short Ratio5.6d
Short % Float5.68%
Short % Out.5.37%
Shares Short11.52M
Short (prev mo.)12.88M
Technical
SMA 50185.70 (+12.4%)
SMA 200125.91 (+65.8%)
Beta1.40
S&P 52W Chg18.16%
Avg Vol (30d)1.65M
Avg Vol (10d)1.54M
Technical Indicators
RSI (14)70.5
MACD8.0680
MACD Signal6.9271
MACD Hist.+1.1410
BB Upper216.85 USD
BB Middle195.99 USD
BB Lower175.14 USD
BB Width21.28%
ATR (14)7.488 USD
Vol Ratio (20d)0.81x